Stifel Maintains Buy on Hinge Health, Raises Price Target to $115
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $96 to $115.
Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $96 to $115.